Get Premium to unlock powerful stock data
Castle Biosciences Inc logo

Castle Biosciences Inc

$ 19.71 +0.74 (+3.9%) 10:08 PM EST
P/E:
At Loss
P/B:
1.21
Market Cap:
$ 517.60M
Enterprise V:
$ 196.05M
Volume:
329.35K
Avg Vol (2M):
382.96K
Volume:
329.35K
Market Cap $:
517.60M
PE Ratio:
At Loss
Avg Vol (2-Month):
382.96K
Enterprise Value $:
196.05M
PB Ratio:
1.21
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Castle Biosciences Inc
NAICS : 621511 SIC : 8071
505 S. Friendswood Drive, Suite 401, Friendswood, TX, USA, 77546
Description
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
Name Current Vs Industry Vs History
Cash-To-Debt 40.8
Equity-to-Asset 0.89
Debt-to-Equity 0.02
Debt-to-EBITDA -0.22
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.6
Distress
Grey
Safe
Beneish M-Score 10.51
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 41.35
9-Day RSI 35.38
14-Day RSI 33.32
6-1 Month Momentum % -45.07
12-1 Month Momentum % -43.3

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 14.21
Quick Ratio 14.13
Cash Ratio 13.25
Days Inventory 50.97
Days Sales Outstanding 62.6
Days Payable 50.52

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -33.6

Financials (Next Earnings Date:2022-08-09 Est.)

CSTL's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:CSTL

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 94.085
EPS (TTM) ($) -1.24
Beta 0
Volatility % 47.87
14-Day RSI 33.32
14-Day ATR ($) 2.26934
20-Day SMA ($) 22.3035
12-1 Month Momentum % -43.3
52-Week Range ($) 17.01 - 78.92
Shares Outstanding (Mil) 26.26

Piotroski F-Score Details

Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Castle Biosciences Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More